Anaesthetic management of Mowat-Wilson syndrome
Sir, First described by D Mowat and M Wilson in 1998, Mowat-Wilson syndrome (MWS) is a very rare genetic condition having multiple facial, gastrointestinal and neurologic features. [1, 2] Our patient, an 18-month-old female child, weighing 6 kg was admitted for repeated episodes of cough, cold, fever, breathlessness with global developmental delay since birth. She was born of non-consanguineous marriage and full-term caesarean section for breech and polyhydramnios.
She was drowsy, hypotonic, hyporeflexic with no social smile, finger grasp or speech. Air entry was decreased on the left with bilateral crepitations. Following facial features were noted: Microcephaly, plagiocephaly, prominent forehead, light coloured sparse hair, medial flaring of eyebrows, prominent eyelashes, depressed nasal bridge, pear shaped nasal tip, inverted V-shaped thick upper lip, everted lower lip, open mouth, pointed chin, malformed and low set ears. She also had mildly everted nipples and proximally placed great toes, clinodactyly 4 th toe and camptodactyly.
Haemoglobin concentration was 9 g %. Chest X-ray revealed hyperinflation and bilateral haziness. Arterial blood gas analysis showed hypoxia and hypoxaemia. Magnetic resonance imaging of the brain showed microcephaly and agenesis of corpus callosum. There were increased protein and decreased sugar levels in cerebrospinal fluid. Auditory evoked potential study showed moderate hearing loss in the right ear. Cytogenetic study showed normal female karyotype. Computed tomography of thorax showed patchy areas of consolidation, in multiple segments (suggestive of aspiration pneumonitis) and rounded well-defined density of 2.8 cm × 2.6 cm involving left para-oesophageal area. After above physical features and investigations, diagnosis of MWS was made. Possibilities of bronchogenic cyst or oesophageal duplication cyst were noted which was planned to be removed surgically. Subsequently, anaesthesia team was involved.
After pre-operative stabilisation and written informed consent, general anaesthesia was planned. Intraoperative monitoring included electrocardiogram, pulse oximetry, temperature, end-tidal CO 2 and neuromuscular monitoring. Premedication included injection glycopyrrolate 30 µg and injection hydrocortisone 15 mg. After careful positioning of patient's head and pre-oxygenation with 100% O 2 for 5 min; sevoflurane was started and increased up to 6%. With altered facial features, ventilation with bag and mask, laryngoscopy and the visualisation of vocal cords proved difficult. She was intubated with difficulty using a Portex™ endotracheal tube uncuffed number 3.5 using a small sized stylet. Intravenous fentanyl 6 µg was used for analgesia. Sevoflurane 2% was used as maintenance agent with oxygen and nitrous oxide in remaining gas (50:50) and atracurium. In supine position, the oesophageal duplication cyst was located, ligated and excised. Blood loss was 20 cc. Reversal of anaesthesia and extubation was uneventful. Paracetamol suppository 180 mg was placed.
MWS is a very rare wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at cephalic, cardiac and vagal levels. [1] This leads to a variety of facial, intestinal and neurological features that are not common in all cases. [2] With only about 200 cases reported, prevalence is about one per 70,000 live births. [3] The inheritance is autosomal dominant. [3] The mutation in the ZEB2 gene on chromosome 2q22 leads to the production of an altered transcription factor resulting in abnormal DNA and protein synthesis at multiple organ system level. [3, 4] Hirschsprung's disease is a feature in two-thirds of cases; its absence may still support diagnosis based on other features. [5] Central nervous system (CNS) features include microcephaly and agenesis of corpus callosum. [6] Management is supportive, symptomatic and prognosis is generally poor. [5] In our patient, we tried to prevent repeated lower respiratory tract infection (LRTI) by taking the risk of surgery to remove the possible source; which was possibly aspiration from oesophageal duplication cyst.
A multidisciplinary approach including paediatric surgeon, paediatrician, genetic consultant and paediatric anaesthesiologist was developed. Pre-operative stabilisation included blood transfusion for anaemia and antibiotics for LRTI. Nebulisation and supplemental oxygen corrected hypoxia. Recurrent aspiration pneumonitis was prevented by treatment with antacids and insertion of Ryle's tube. For possible malignant hyperthermia risk, cold ice packs, anti-arrhythmics were kept ready. Omission of succinylcholine, adequate monitoring of electrocardiogram, temperature and neuromuscular status was done for the same. Difficult intubation cart was kept ready. Pre-operative sedation was avoided considering the risk of respiratory and CNS depression. Other rationale behind the omission of succinylcholine was the presence of hypotonia, dystonia, risk of long QT syndrome, hyperkalemia and malignant hyperthermia. [7] Use of non-depolarising muscle relaxant was also avoided initially in view of difficult intubation. Due to its rapid induction and recovery, safety in the presence of agenesis of corpus callosum, and less incidence of malignant hyperthermia, sevoflurane was used. [8] Thus, the main anaesthetic challenges in MWS are a risk of malignant hyperthermia, difficult intubation, and possibility of difficulty in weaning, LRTI and anaemia. Thorough knowledge of this very rare syndrome and a multidisciplinary approach is necessary for successful outcome. The patient's parents did not consent of publication of images but consented for publication of the case.
Anaesthetic challenges in a child with sickle-cell disease and congenital heart block
Sir,
We present a case report of anaesthetic management of a 12-year-old boy with sickle-cell disease (SCD) and congenital heart block (CHB) with pacemaker [ Figure 1 ], undergoing laparoscopic splenectomy.
The child had suffered sickle-cell crisis and pacemaker malfunction a month back. His preoperative investigations were normal and weight was 30 kg. He received intravenous (IV) fluids during fasting period, pneumococcal vaccine, antibiotic prophylaxis and cefotaxime 500 g IV. The cardiologist changed the mode of pacemaker to asynchronous (fixed rate). Standard American Society of Anesthesiologists monitoring, urine output and temperature monitoring were used. Morphine 4.5 mg IV, thiopentone 150 mg IV and atracurium 0.5 mg/kg IV were used for induction and intubation. Anaesthesia was maintained with isoflurane (MAC: 1.0), air and oxygen (FiO 2 : 0.5). Pneumoperitoneum was created with CO 2 and intra-abdominal pressure was kept around 8-10 mmHg. The surgeon used bipolar cautery, blood loss was approximately 800 ml and 1 unit packed red cell was transfused. The patient was given fluid at 60 ml/h intra-operatively as he had been kept hydrated preoperatively. For post-operative analgesia, paracetamol 500 mg IV was given and skin incision was infiltrated with 12 ml 0.2% ropivacaine. Neuromuscular blockade was reversed and trachea was extubated. The patient remained haemodynamically stable, normothermic and had adequate urine output. Post-operative analgesia was maintained with paracetamol 500 mg IV 8 th hourly and fentanyl boluses of 30 µg as rescue analgesic whenever visual analogue scale exceeded 3. The child was discharged on the 7 th post-operative day after uneventful course. CHB (incidence 1 in 22,000 live births) with no structural abnormality and when diagnosis is established beyond neonatal period has better survival. [1] Intraoperatively, pacemaker mode is advised to be changed to asynchronous, and bipolar electrocautery is to be used. The availability of manual pacing should be ensured to manage pacemaker malfunction. [2] SCD is the disorder of beta-globin chain characterised by haemolytic anaemia, intermittent vascular occlusion, pulmonary compromise and multi-organ damage. Electrocardiogram changes are non-specific 
